Clout wars: Jensen Huang eclipses Elon Musk and Tim Cook in Washington

Clout wars: Jensen Huang eclipses Elon Musk and Tim Cook in Washington

In the evolving landscape of U.S.-China relations during the Trump administration, Nvidia CEO Jensen Huang has emerged as a significant player, overshadowing Apple’s Tim Cook and Tesla’s Elon Musk. While Cook previously cultivated strong ties with Washington and Beijing, the current political atmosphere sees Huang's influence growing due to Nvidia’s pivotal role in the AI sector. According to industry experts, Huang's leadership has positioned him as a crucial political figure, particularly following Nvidia’s announcement of resuming sales of its H20 AI chips to China. This decision comes after earlier restrictions on the chip exports, which Huang actively campaigned against, signaling his ability to navigate complex political terrains. Dan Ives from Wedbush noted that Huang's status as a leading figure in the AI revolution has significantly elevated his political relevance, stating, "There is only one chip in the world fueling the AI revolution, and that's Nvidia's." His recent meetings with Trump, including a visit to Beijing, have reinforced his standing and capability in influencing trade negotiations. The lifting of the export restrictions on the H20 chip is seen as a notable victory for Huang and Nvidia, reflecting the growing political leverage he wields within the Trump administration. As the U.S. and China engage in trade discussions, Huang's lobbying efforts have been recognized as instrumental in reshaping the narrative surrounding U.S. tech leadership. In addition to his advocacy against chip restrictions, Huang has been involved in significant agreements, such as a massive AI deal with the United Arab Emirates, showcasing Nvidia's strategic role in bolstering U.S. technological dominance amid global competition. While Cook's earlier influence appears to be waning, with recent criticisms from Trump regarding Apple's operations, Huang's ascent highlights a shift in power dynamics within the tech industry. Experts suggest that while Huang currently holds a strong position, the future remains uncertain, especially as the U.S. considers broader tariffs on the semiconductor industry, which could impact Nvidia's operations. As the tech landscape continues to evolve, Huang's ability to maintain his influence will be crucial, emphasizing the delicate balance of managing relationships with both U.S. and Chinese markets.

Sources : CNBC

Published On : Jul 22, 2025, 09:05

AI
Inside the Fast-Paced World of Meta's Superintelligence Labs: Insights from an AI Researcher

Navigating the landscape of cutting-edge AI research can be exhilarating yet demanding. Prakhar Agarwal, an applied rese...

Business Insider | Mar 11, 2026, 04:25
Inside the Fast-Paced World of Meta's Superintelligence Labs: Insights from an AI Researcher
AI
AI Apps Face Tough Challenge in Keeping Subscribers, New Study Reveals

As the app marketplace becomes increasingly saturated with artificial intelligence applications, developers may be tempt...

TechCrunch | Mar 10, 2026, 21:25
AI Apps Face Tough Challenge in Keeping Subscribers, New Study Reveals
Startups
Kalshi Enhances Engagement on Threads with New Sharing Feature

Kalshi, the prediction market platform, is enhancing user interaction on Meta's Threads by introducing a new sharing fea...

TechCrunch | Mar 10, 2026, 23:40
Kalshi Enhances Engagement on Threads with New Sharing Feature
Computing
Google Expands Gemini Features in Chrome to Enhance User Experience in India and Beyond

On Wednesday, Google revealed its plans to expand the integration of Gemini into Chrome for several new countries, inclu...

TechCrunch | Mar 11, 2026, 02:50
Google Expands Gemini Features in Chrome to Enhance User Experience in India and Beyond
Science
FDA's Unexpected Decision Leaves Autism Treatment Hopes Unfulfilled

In a surprising turn of events, the FDA has chosen not to approve the use of the generic drug leucovorin for treating au...

Ars Technica | Mar 10, 2026, 22:15
FDA's Unexpected Decision Leaves Autism Treatment Hopes Unfulfilled
View All News